Interview with Health Europe Quaterly

Stefania Vallone

Stefania Vallone, LuCE president, spoke to Health Europe Quaterly about the disparities and barriers that remain in access to innovative lung cancer diagnostics, drugs, and services. The main topics were: the key barriers to faster access to treatment, diagnostic an care in Europe; how financial pressure and high costs of new drugs impact should be addressed; how important are clinical trials for lung cancer patients. You can read the interview here

Spread the word. Share this post!